Latest Capital Markets News

TMK Energy Limited has successfully passed all resolutions at its recent General Meeting, including a significant share placement involving directors and a substantial consolidation of its capital structure.

Red Mountain Mining has bolstered its critical minerals portfolio with key acquisitions in the US and promising exploration outcomes across its global projects, supported by a recent $1.5 million capital raise.

MPR Australia Limited has finalized the sale of its core renewable energy business for approximately $19 million, marking a significant strategic shift. The company now plans to explore options including returning capital to shareholders or acquiring a new business.

Cyprium Metals has completed a transformative A$80 million capital raise to fund the phased restart of copper production at its Nifty Copper Complex, positioning the company for operational progress and exploration growth.

Avecho Biotechnology advances its pivotal Phase III CBD insomnia trial with 160 patients dosed and secures $2.5 million to accelerate manufacturing and regulatory efforts ahead of a 2026 interim analysis.

Jameson Resources has made significant strides in advancing its Crown Mountain Hard Coking Coal Project, progressing environmental assessments and Indigenous partnerships while securing fresh capital to support development.

Santana Minerals reports robust progress on its Bendigo-Ophir Gold Project with an updated Pre-Feasibility Study, strategic land acquisitions, and a substantial capital raise, positioning the project for development in 2026.

Northern Minerals Limited reported a net operating cash outflow of AUD 6.61 million for Q3 2025, ending the quarter with AUD 17.48 million in cash and equivalents and a solid financing facility.

NoviqTech Limited has launched Fuel Central for sustainable fuels traceability and established Quantum Intelligence Pty Ltd to advance quantum computing and AI applications, backed by a $1.08 million placement. The company also refreshed its board and expanded its international footprint.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

Stakk Limited reports a staggering 1,836% year-on-year increase in quarterly receipts, positioning itself on track to hit an $8 million annual recurring revenue target by mid-2026.

ADX Energy reports a 17% production dip in Q3 2025 due to well downtime but boosts sales revenue by 23%, while advancing drilling plans and acquiring key infrastructure.